JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 61.25
+6.40 (11.67%)
Aug 15, 2025, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 196.01 billion as of August 15, 2025. Its market cap has increased by 199.05% in one year.
Market Cap
196.01B
Enterprise Value
145.87B
Revenue
71.34B
Ranking
n/a
PE Ratio
37.75
Stock Price
61.25
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 196.01B, a decrease of -43.02%. That is a compound annual growth rate of -11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 196.01B | 118.08% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| Innovent Biologics | 162.71B |
| Akeso | 141.46B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |
| Sichuan Kelun-Biotech Biopharmaceutical | 95.62B |